George Penesis

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
It is well established that haematological malignancies could develop during the clinical course of Inflammatory Bowel Disease (IBD).1,2 Epidemiological data suggest that this risk might be increased3 and be related with the use of either immunosuppressants or biologic agents.4 So far, these malignancies have been observed after the establishment of(More)
  • 1